Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes

NCT00791479 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

167

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY2189265 and Lifestyle Measures
DRUG: Placebo solution and Lifestyle Measures

Sponsor

Eli Lilly and Company